Cargando…
Propionic acid beneficially modifies osteoporosis biomarkers in patients with multiple sclerosis
BACKGROUND: The impact of the gut and its microbiota are increasingly appreciated in health and disease. Short-chain fatty acids (SCFAs) are among the main metabolites synthesized from bacterial fermentation. Recently, we showed the anti-inflammatory and potentially neuroprotective effect of propion...
Autores principales: | Duscha, Alexander, Hegelmaier, Tobias, Dürholz, Kerstin, Desel, Christiane, Gold, Ralf, Zaiss, Mario M., Haghikia, Aiden |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218497/ https://www.ncbi.nlm.nih.gov/pubmed/35755968 http://dx.doi.org/10.1177/17562864221103935 |
Ejemplares similares
-
Functional and structural readouts for early detection of retinal involvement in multiple sclerosis
por: Al-Nosairy, Khaldoon O., et al.
Publicado: (2023) -
Predictors for Therapy Response to Intrathecal Corticosteroid Therapy in Multiple Sclerosis
por: Vohl, Katja, et al.
Publicado: (2019) -
Propionic Acid Rescues High-Fat Diet Enhanced Immunopathology in Autoimmunity via Effects on Th17 Responses
por: Haase, Stefanie, et al.
Publicado: (2021) -
The NRF2 pathway as potential biomarker for dimethyl fumarate treatment in multiple sclerosis
por: Hammer, Anna, et al.
Publicado: (2018) -
Propionic Acid and Fasudil as Treatment against Rotenone Toxicity in an In Vitro Model of Parkinson’s Disease
por: Ostendorf, Friederike, et al.
Publicado: (2020)